AAM Urges CMS To Enforce Its Rightful Power Over Medicare Part D Formularies

As HHS Secretary Nominee RFK Jr. Braces Though Questions During Confirmation Hearings

While the AAM encouraged CMS to impose its “clear authority” to regulate Medicare Part D formularies, the agency announced that the Trump administration will continue the second cycle of Medicare price negotiations, which has been criticized by the US off-patent trade group.

Centers for Medicare and Medicaid Services website
(Shutterstock)

All eyes are on the US, as the country marks a tumultuous political start to the year, with many questions raised over the future of its healthcare system.

Indeed, as the Association for Accessible Medicines put it, at a time when public opinion is often divided, Americans are...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation